Hepatic intra-arterial infusion of yttrium-90 microspheres in the treatment of recurrent hepatocellular carcinoma after liver transplantation: A case report

World Journal of Gastroenterology

Volumn 12, Issue 35, 2006, Pages 5729-5732

  Rivera, Louis ^a   Giap, Huan ^b   Miller, William ^b   Fisher, Jonathan ^b   Hillebrand, Donald J ^b   Marsh, Christopher ^b   Schaffer, Randolph L ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b SCRIPPS CLINIC   (United States)

Author keywords

Liver transplantation; Recurrent hepatocellular carcinoma; Yttrium 90 microspheres

Indexed keywords

ALPHA FETOPROTEIN; AZATHIOPRINE; BASILIXIMAB; DOXORUBICIN; METHYLPREDNISOLONE; PEGINTERFERON; PREDNISOLONE; RADIOACTIVE MICROSPHERE; RAPAMYCIN; RIBAVIRIN; TACROLIMUS; VIRUS RNA; YTTRIUM 90;

ADULT; ALLOTRANSPLANTATION; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INFUSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER RESECTION; LIVER TRANSPLANTATION; MALE; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION;

EID: 33750110064     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i35.5729     Document Type: Article

References (11)

1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699
2. Island ER, Pomposelli J, Pomfret EA, Gordon FD, Lewis WD, Jenkins RL. Twenty-year experience with liver transplantation for hepatocellular carcinoma. Arch Surg 2005; 140: 353-358
3. Vivarelli M, Bellusci R, Cucchetti A, Cavrini G, De Ruvo N, Aden AA, La Barba G, Brillanti S, Cavallari A. Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression? Transplantation 2002; 74: 1746-1751
4. Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, Krieger NR, Schwartz ME. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 2004; 10: 534-540
5. Kulik LM, Mulcahy MF, Hunter RD, Nemcek AA Jr, Abecassis MM, Salem R. Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report. Liver Transpl 2005; 11: 1127-1131
6. Chan AO, Yuen MF, Hui CK, Tso WK, Lai CL. A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer 2002; 94: 1747-1752
7. Carr BI. Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 2004; 10: S107-110
8. Salem R, Thurston KG, Carr BI, Goin JE, Geschwind JF. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 2002; 13: S223-229
9. Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol 2005; 16: 195-203
10. Steel J, Baum A, Carr B. Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of Cisplatin versus 90-Yttrium microspheres (Therasphere). Psychooncology 2004; 13: 73-79
11. Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 2005; 16: 205-213